Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.754
-0.006 (-0.79%)
At close: Apr 28, 2026, 4:00 PM EDT
0.754
-0.000 (-0.05%)
After-hours: Apr 28, 2026, 4:16 PM EDT
Mustang Bio Market Cap
Mustang Bio has a market cap or net worth of $5.71 million as of April 28, 2026. Its market cap has increased by 29.84% in one year.
Market Cap
5.71M
Enterprise Value
-11.56M
1-Year Change
29.84%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since August 22, 2017, Mustang Bio's market cap has decreased from $257.00M to $5.71M, a decrease of -97.78%. That is a compound annual growth rate of -35.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.80M | -19.44% |
| Dec 31, 2025 | 7.20M | -15.29% |
| Dec 31, 2024 | 8.50M | -31.45% |
| Dec 29, 2023 | 12.40M | -70.75% |
| Dec 30, 2022 | 42.40M | -72.66% |
| Dec 31, 2021 | 155.10M | -37.18% |
| Dec 31, 2020 | 246.90M | 49.18% |
| Dec 31, 2019 | 165.50M | 106.36% |
| Dec 31, 2018 | 80.20M | -74.50% |
| Dec 29, 2017 | 314.50M | 22.37% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 6.33M |
| Purple Biotech | 6.23M |
| CollPlant Biotechnologies | 6.00M |
| BioRestorative Therapies | 5.86M |
| Aptevo Therapeutics | 5.76M |
| Ernexa Therapeutics | 5.59M |
| PMGC Holdings | 5.48M |
| Jaguar Health | 5.45M |